17-42537595-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000263.4(NAGLU):​c.531+50G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.729 in 1,603,722 control chromosomes in the GnomAD database, including 428,346 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.74 ( 42250 hom., cov: 32)
Exomes 𝑓: 0.73 ( 386096 hom. )

Consequence

NAGLU
NM_000263.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.634

Publications

19 publications found
Variant links:
Genes affected
NAGLU (HGNC:7632): (N-acetyl-alpha-glucosaminidase) This gene encodes an enzyme that degrades heparan sulfate by hydrolysis of terminal N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. This disease is characterized by the lysosomal accumulation and urinary excretion of heparan sulfate. [provided by RefSeq, Jul 2008]
NAGLU Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 3B
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P, Orphanet, Myriad Women’s Health
  • Charcot-Marie-Tooth disease axonal type 2V
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 17-42537595-G-C is Benign according to our data. Variant chr17-42537595-G-C is described in ClinVar as Benign. ClinVar VariationId is 195051.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.786 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000263.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGLU
NM_000263.4
MANE Select
c.531+50G>C
intron
N/ANP_000254.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NAGLU
ENST00000225927.7
TSL:1 MANE Select
c.531+50G>C
intron
N/AENSP00000225927.1
NAGLU
ENST00000586516.5
TSL:2
c.133-744G>C
intron
N/AENSP00000467135.1
NAGLU
ENST00000591587.1
TSL:5
c.127-744G>C
intron
N/AENSP00000467836.1

Frequencies

GnomAD3 genomes
AF:
0.744
AC:
113006
AN:
151938
Hom.:
42215
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.750
Gnomad AMI
AF:
0.784
Gnomad AMR
AF:
0.798
Gnomad ASJ
AF:
0.823
Gnomad EAS
AF:
0.738
Gnomad SAS
AF:
0.591
Gnomad FIN
AF:
0.714
Gnomad MID
AF:
0.690
Gnomad NFE
AF:
0.740
Gnomad OTH
AF:
0.726
GnomAD2 exomes
AF:
0.737
AC:
175008
AN:
237328
AF XY:
0.726
show subpopulations
Gnomad AFR exome
AF:
0.756
Gnomad AMR exome
AF:
0.839
Gnomad ASJ exome
AF:
0.822
Gnomad EAS exome
AF:
0.732
Gnomad FIN exome
AF:
0.714
Gnomad NFE exome
AF:
0.737
Gnomad OTH exome
AF:
0.741
GnomAD4 exome
AF:
0.728
AC:
1056631
AN:
1451666
Hom.:
386096
Cov.:
38
AF XY:
0.724
AC XY:
522611
AN XY:
722092
show subpopulations
African (AFR)
AF:
0.743
AC:
24753
AN:
33330
American (AMR)
AF:
0.831
AC:
36705
AN:
44146
Ashkenazi Jewish (ASJ)
AF:
0.826
AC:
21470
AN:
26004
East Asian (EAS)
AF:
0.741
AC:
29281
AN:
39516
South Asian (SAS)
AF:
0.602
AC:
51552
AN:
85584
European-Finnish (FIN)
AF:
0.712
AC:
34590
AN:
48574
Middle Eastern (MID)
AF:
0.698
AC:
3379
AN:
4842
European-Non Finnish (NFE)
AF:
0.731
AC:
811166
AN:
1109640
Other (OTH)
AF:
0.729
AC:
43735
AN:
60030
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
16339
32678
49017
65356
81695
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20034
40068
60102
80136
100170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.744
AC:
113090
AN:
152056
Hom.:
42250
Cov.:
32
AF XY:
0.741
AC XY:
55068
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.750
AC:
31131
AN:
41496
American (AMR)
AF:
0.798
AC:
12200
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.823
AC:
2855
AN:
3468
East Asian (EAS)
AF:
0.738
AC:
3795
AN:
5144
South Asian (SAS)
AF:
0.591
AC:
2850
AN:
4824
European-Finnish (FIN)
AF:
0.714
AC:
7557
AN:
10584
Middle Eastern (MID)
AF:
0.690
AC:
203
AN:
294
European-Non Finnish (NFE)
AF:
0.740
AC:
50265
AN:
67936
Other (OTH)
AF:
0.721
AC:
1519
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1507
3014
4522
6029
7536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.763
Hom.:
8197
Bravo
AF:
0.752
Asia WGS
AF:
0.644
AC:
2238
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 08, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Charcot-Marie-Tooth disease axonal type 2V Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mucopolysaccharidosis, MPS-III-B Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
1.8
DANN
Benign
0.34
PhyloP100
-0.63
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071046; hg19: chr17-40689613; COSMIC: COSV56794442; COSMIC: COSV56794442; API